School of Medicine - Clinical Medicine
Breast and Endocrine Surgery
Outline
Breast cancer is the most prevalent malignancy among women in Japan. The department of breast and endocrine surgery was established in 2009, and the breast center started in 2016. There are currently several effective treatments for breast cancer involving surgery, radiotherapy, chemotherapy, monoclonal antibody therapy, and hormonal therapy. Therefore, surgeons must understand not only the surgical treatments but also have a multidisciplinary approach. Nevertheless, surgery is an integral part of the treatment of breast cancer. We have developed two types of breast surgery: (1) a novel oncoplastic technique for breast cancer localized in the lower pole of the breast, and (2) axillary reverse mapping with indocyanine fluorescence imaging.
Contact Information
TEL: 076-218-8301 (内線: 35239)
/ FAX: 076-218-8301
e-mail: brstsurg【＠】kanazawa-med.ac.jp
e-mail: brstsurg【＠】kanazawa-med.ac.jp
Faculty
Research Achievements
-
The involvement of axillary reverse mapping nodes in patients with clinically node-negative breast cancerM.noguchi,M.inokuchi,M.Yokoi-Noguchi,E.Morioka BreastCancer volume29,issue2,March2022
- Inokuchi M, Kutomi G, Kijima Y, Sakai T, Sawaki M, Shien T, Hanamura N, Yano K, Wada N, Saji S, Iwata H.
The Japanese Breast Cancer Society clinical practice guidelines for surgical treatment of breast cancer, 2018 edition. Breast Cancer. 2020; 27(1):4-8. - Noguchi M, Ohno Y, Morioka E, Noguchi M, Nakano Y, Kosaka T, Shimada KI.
A novel oncoplastic technique for breast cancer localized in the lower pole of the breast.
J Surg Oncol. 2018; 117(2):137-141. - Noguchi M, Yokoi-Noguchi M, Ohno Y, Morioka E, Nakano Y, Kosaka T, Kurita T.
Oncoplastic breast conserving surgery: Volume replacement vs. volume displacement.
Eur J Surg Oncol. 2016; 42(7):926-34. - Noguchi M, Noguchi M, Ohno Y, Morioka E, Nakano Y, Kosaka T, Kurose N, Minato H.
Feasibility study of axillary reverse mapping for patients with clinically node-negative breast cancer.
Eur J Surg Oncol. 2016; 42(5):650-6.